Name
Updating the Alzheimer’s disease patient journey: Presenting pivotal and 36-month long-term extension results & a monthly maintenance dosing regimen Sponsored by Eisai Inc.
Speakers
Content Presented on Behalf of
Product Theater Sponsor: Eisai Inc.
Session Type
Product Theater
Date
Tuesday, March 4, 2025
Start Time
12:45 PM
End Time
1:15 PM
Room#/Location
Prince Georges Exhibit Hall A/B
Focus Areas/Topics
Behavioral and Mental Health, Clinical Care, Trending/Hot Topics or Other not listed
CE/CME Session
Non-CE Session
Session Currently Live
Description
The treatment paradigm for Alzheimer’s disease (AD) is evolving rapidly with the introduction of innovative AD diagnostic tools and therapies – impacting the care management of AD and shifting the patient journey towards earlier identification, treatment initiation, and possibly altering disease progression.
During this program, we will review the patient journey steps to treatment with a therapy and discuss:
- Identification of patients with signs of early AD
- Selection of appropriate patients for therapy
- Considerations for initiating treatment
- Observation and monitoring for safety, and
- Presentation of pivotal and 36-month long-term extension results
- A monthly maintenance dosing regimen option